| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relmada Therapeutics, Inc. (RLMD) has 7 insiders with recent SEC Form 4 filings, including 20 buys and 0 sells. RLMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.30M | $9.52M | - | |
| COO | 828.0K | $6.06M | - | |
| Other | 828.0K | $6.06M | - | |
| CFO | 800.0K | $5.86M | - | |
| Dir | 164.0K | $1.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | Kelly Paul Edward53 | Chief Operating Officer | Buy | 200,000 | $0.43 | $86,060.00 | +94.2% | +31.7% | - | |
| Sep 11, 2024 | Traversa Sergio55 | Chief Executive Officer | Buy | 140,000 | $2.82 | $395,114.52 | +16.0% | -84.4% | -49.7% | |
| Sep 11, 2024 | Shenouda Maged | Chief Financial Officer | Buy | 53,432 | $2.80 | $149,700.84 | +37.6% | -84.4% | -49.7% | |
| Sep 9, 2024 | Kelly Paul Edward53 | Director | Buy | 25,000 | $2.59 | $64,750.00 | +13.3% | -82.8% | -44.1% | |
| Sep 9, 2024 | Casamento Charles J71 | Director | Buy | 13,000 | $2.56 | $33,280.00 | New | -82.8% | -44.1% | |
| Jan 31, 2024 | Traversa Sergio55 | Chief Executive Officer | Buy | 100,000 | $3.87 | $386,737.56 | +18.7% | -7.4% | -91.0% | |
| Jan 31, 2024 | Shenouda Maged | Chief Financial Officer | Buy | 32,675 | $3.85 | $125,716.68 | +75.5% | -7.4% | -91.0% | |
| Jan 31, 2024 | Ence Chuck | Ca And Co | Buy | 38,970 | $3.87 | $150,920.13 | +108.0% | -7.4% | -91.0% | |
| May 23, 2023 | O'Gorman Cedric | Chief Medical Officer | Buy | 10,000 | $3.18 | $31,800.00 | +8,264% | -4.2% | -1.3% | |
| Dec 8, 2022 | Traversa Sergio55 | Chief Executive Officer | Buy | 55,250 | $2.10 | $115,804.00 | +62.2% | +51.6% | +18.0% |